Jill Stein

All articles by Jill Stein

Dual Regimen Benefits Obese Patients

NEW ORLEANS—The combination of sustained-release naltrexone and bupropion leads to sustained clinically meaningful weight loss and improves markers of cardiovascular risk in obese patients, according to results released at the 60th Annual Scientific Session of the American College of Cardiology.

Two-Drug Combination May Improve Lipid Goals

New results suggest that combination therapy with ezetimibe/simvastatin, when prescribed at the recommended starting and next higher doses, is more likely to improve lipids than atorvastatin alone in patients with metabolic syndrome.

Next post in Hypertension